Education
About Us
Working with TipRanks
Follow Us
Endra Life Sciences (NDRA)
:NDRA
NDRA Stock Chart & Stats
$7.00
-$0.12(-1.95%)
At close: 4:00 PM EST
$7.00
-$0.12(-1.95%)
Day’s Range― - ―
52-Week Range$2.90 - $22.68
Previous CloseN/A
Volume13.45K
Average Volume (3M)510.97K
Market Cap
$5.27M
Enterprise Value$1.27M
Total Cash (Recent Filing)$1.81M
Total Debt (Recent Filing)$557.49K
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Nov 17, 2025EPS Estimate
-1.95Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.71
Shares Outstanding752,755
10 Day Avg. Volume1,459,484
30 Day Avg. Volume510,972
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.24
Enterprise Value/Revenue5.98
Enterprise Value/Gross Profit46.16
Enterprise Value/Ebitda-0.16
Forecast
1Y Price Target
$38.00Price Target Upside442.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Market OpportunityThe launch of the TAEUS application for early detection of Steatotic Liver Disease opens a large market opportunity.
Product DevelopmentENDRA's TAEUS platform offers a cost-effective alternative to CT and MRI, enabling new ways to visualize human tissue composition at the point-of-care.
Bears Say
Price TargetThe 12-month price target for ENDRA has been lowered from $50 to $46, despite maintaining a BUY rating.
Revenue GenerationENDRA is a late stage medical device development/early stage commercialization company so it generates no revenues.
ENDRA Life Sciences News
NDRA FAQ
What was Endra Life Sciences’s price range in the past 12 months?
Endra Life Sciences lowest stock price was $2.90 and its highest was $22.68 in the past 12 months.
What is Endra Life Sciences’s market cap?
Endra Life Sciences’s market cap is $5.27M.
When is Endra Life Sciences’s upcoming earnings report date?
Endra Life Sciences’s upcoming earnings report date is Nov 17, 2025 which is in 30 days.
How were Endra Life Sciences’s earnings last quarter?
Endra Life Sciences released its earnings results on Jun 30, 2025. The company reported -$1.71 earnings per share for the quarter, beating the consensus estimate of -$2.27 by $0.56.
Is Endra Life Sciences overvalued?
According to Wall Street analysts Endra Life Sciences’s price is currently Undervalued.
Does Endra Life Sciences pay dividends?
Endra Life Sciences does not currently pay dividends.
What is Endra Life Sciences’s EPS estimate?
Endra Life Sciences’s EPS estimate is -1.95.
How many shares outstanding does Endra Life Sciences have?
Endra Life Sciences has 752,755 shares outstanding.
What happened to Endra Life Sciences’s price movement after its last earnings report?
Endra Life Sciences reported an EPS of -$1.71 in its last earnings report, beating expectations of -$2.27. Following the earnings report the stock price went down -2.564%.
Which hedge fund is a major shareholder of Endra Life Sciences?
Currently, no hedge funds are holding shares in NDRA
Company Description
Endra Life Sciences
ENDRA Life Sciences (NDRA) is a medical technology company that operates in the healthcare sector. The company is focused on developing innovative diagnostic tools, particularly in the field of liver disease. ENDRA's flagship product is the Thermo Acoustic Enhanced Ultrasound (TAEUS) system, which aims to provide a cost-effective and non-invasive solution for assessing liver fat content, aiding in the management of conditions such as non-alcoholic fatty liver disease (NAFLD). The TAEUS system is designed to work alongside standard ultrasound systems, enhancing their capabilities with ENDRA's proprietary technology.
NDRA Stock 12 Month Forecast
Average Price Target
$38.00
▲(442.86% Upside)
Technical Analysis
Ownership Overview
2.15% Insiders
0.54% Mutual Funds
― Other Institutional Investors
97.30% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---